Actualités id1251.html

Images about id1251.html

Ibrutinib for treating relapsed or refractory follicular lymphoma and marginal zone lymphoma [ID1251]

Wed, 06 Nov 2024 16:00:00 GMT

Please note that following on from information provided to NICE by the company in July 2023, the appraisal was suspended from NICE’s work programme. As no further information has been received from ...